Terry Hermiston

Terry Hermiston

Fondatore presso Coagulant Therapeutics, Inc.

Health Technology
Commercial Services

Provenienza dei contatti di primo grado di Terry Hermiston

EntitàTipo di entitàSettore Industriale
7
Holding Company Pharmaceuticals: Major 7
6
Holding Company Pharmaceuticals: Major 6
3
Subsidiary Pharmaceuticals: Major 3

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Terry Hermiston tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Jon Wigginton

Corporate Officer/Principal

PEGASYSTEMS INC. Information Technology Services

Richard Jones

Director/Board Member

Pharmaceuticals: Major

David Kirn

Chief Tech/Sci/R&D Officer

INTERMUNE INC Biotechnology

Robin Steele

General Counsel

Pharmaceuticals: Major

Robin Steele

General Counsel

SUTRO BIOPHARMA, INC. Pharmaceuticals: Major

Jon Wigginton

Director/Board Member

Miscellaneous Commercial Services

David Kirn

Helena H. Chaye

Founder

Corporate Officer/Principal

Pharmaceuticals: Major

Richard Jones

Helena H. Chaye

Director/Board Member

Chief Executive Officer

College/University

David Kirn

Corporate Officer/Principal

University of Oxford College/University

David Kirn

Corporate Officer/Principal

MACROGENICS, INC. Pharmaceuticals: Major

Jon Wigginton

Chief Tech/Sci/R&D Officer

Engineering & Construction

Richard Jones

Corporate Officer/Principal

Pharmaceuticals: Major

Helena H. Chaye

Corporate Officer/Principal

Dalhousie University College/University

Helena H. Chaye

Graduate Degree

University of British Columbia College/University

Helena H. Chaye

Doctorate Degree

University of California, Berkeley College/University

David Kirn

Undergraduate Degree

The University of Colorado College/University

Robin Steele

Undergraduate Degree

University of Michigan College/University

Jon Wigginton

Doctorate Degree

General Government

David Kirn

Corporate Officer/Principal

Miscellaneous Commercial Services

David Kirn

Corporate Officer/Principal

Investment Managers

Richard Jones

Corporate Officer/Principal

Pharmaceuticals: Major

Jon Wigginton

Corporate Officer/Principal

Pharmaceuticals: Major

Jon Wigginton

Director/Board Member

Miscellaneous Commercial Services

Helena H. Chaye

Corporate Officer/Principal

Center for Cancer Research General Government

Jon Wigginton

Corporate Officer/Principal

University of California, Hastings College/University

Robin Steele

Graduate Degree

Fleet Investment Services, Inc.

Richard Jones

Chief Executive Officer

Medical/Nursing Services

David Kirn

Corporate Officer/Principal

Drugstore Chains

Robin Steele

Director/Board Member

New York University School of Law College/University

Robin Steele

Graduate Degree

4D MOLECULAR THERAPEUTICS, INC. Biotechnology

David Kirn

Founder

CHECKMATE PHARMACEUTICALS, INC. Biotechnology

Jon Wigginton

Director/Board Member

Pharmaceuticals: Major

Robin Steele

Director/Board Member

Medical Specialties

Robin Steele

Director/Board Member

DARÉ BIOSCIENCE, INC. Pharmaceuticals: Major

Robin Steele

Director/Board Member

Biotechnology

Jon Wigginton

Chief Tech/Sci/R&D Officer

Gladiator Biosciences, Inc.

Robin Steele

Director/Board Member

DTCP Management GmbH Investment Managers

Mankyu Park

Corporate Officer/Principal

Biotechnology

David Kirn

Founder

Miscellaneous Commercial Services

Jon Wigginton

President

CULLINAN THERAPEUTICS, INC. Pharmaceuticals: Major

Jon Wigginton

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Frank Misselwitz

Chief Tech/Sci/R&D Officer

Food: Specialty/Candy

Tom Leonard

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 42
Regno Unito 4
Canada 4
Emirati Arabi Uniti 2
Svizzera 2

Settori

Health Technology 22
Consumer Services 10
Commercial Services 8
Finance 5
Government 3

Posizioni

Director/Board Member 31
Corporate Officer/Principal 22
Chief Tech/Sci/R&D Officer 9
Founder 6
Undergraduate Degree 5
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA